{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,12,21]],"date-time":"2024-12-21T07:10:23Z","timestamp":1734765023918,"version":"3.32.0"},"reference-count":33,"publisher":"Informa UK Limited","license":[{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/3.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["DNND"],"DOI":"10.2147\/dnnd.s484306","type":"journal-article","created":{"date-parts":[[2024,12,21]],"date-time":"2024-12-21T06:30:13Z","timestamp":1734762613000},"page":"131-141","source":"Crossref","is-referenced-by-count":0,"title":["Autoinjectors for Administering Glatiramer Acetate in Relapsing Remitting Multiple Sclerosis in Europe: A Survey of Patient and Nurse Preferences"],"prefix":"10.2147","volume":"Volume 14","author":[{"given":"Santosh","family":"Shirol","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Riyaz","family":"Saboor","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6799-0753","authenticated-orcid":true,"given":"Thomas","family":"M\u00fcller","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"301","published-online":{"date-parts":[[2024,12]]},"reference":[{"key":"ref1","doi-asserted-by":"publisher","first-page":"1022","DOI":"10.1212\/WNL.0000000000000768","volume":"83","author":"Browne","year":"2014","journal-title":"Neurology"},{"key":"ref2","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1038\/s41572-018-0041-4","volume":"4","author":"Filippi","year":"2018","journal-title":"Nature Reviews Disease Primers"},{"key":"ref3","doi-asserted-by":"publisher","first-page":"1816","DOI":"10.1177\/1352458520970841","volume":"26","author":"Walton","year":"2020","journal-title":"Mult Scler"},{"key":"ref4","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1016\/j.dhjo.2017.04.008","volume":"11","author":"Amtmann","year":"2018","journal-title":"Disabil Health J"},{"key":"ref5","doi-asserted-by":"publisher","first-page":"453","DOI":"10.1177\/1352458520913977","volume":"27","author":"Sadigh","year":"2020","journal-title":"Mult Scler J"},{"key":"ref6","doi-asserted-by":"publisher","first-page":"a028928","DOI":"10.1101\/cshperspect.a028928","volume":"8","author":"Klineova","year":"2018","journal-title":"Cold Spring Harb Perspect Med"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1016\/B978-0-444-52001-2.00010-8","volume":"122","author":"Goodin","year":"2014","journal-title":"Handbook Clin Neurol"},{"key":"ref8","doi-asserted-by":"publisher","first-page":"e20885","DOI":"10.1097\/MD.0000000000020885","volume":"99","author":"Xie","year":"2020","journal-title":"Medicine"},{"key":"ref9","doi-asserted-by":"publisher","first-page":"s53","DOI":"10.7861\/clinmedicine.16-6-s53","volume":"16","author":"Doshi","year":"2016","journal-title":"Clin Med Lond"},{"key":"ref10","doi-asserted-by":"publisher","first-page":"199","DOI":"10.31128\/ajgp-07-21-6103","volume":"51","author":"Travers","year":"2022","journal-title":"Aust J Gen Pract"},{"key":"ref11","doi-asserted-by":"publisher","first-page":"825","DOI":"10.2165\/00023210-200216120-00004","volume":"16","author":"Simpson","year":"2002","journal-title":"CNS Drugs"},{"key":"ref12","doi-asserted-by":"publisher","first-page":"425","DOI":"10.1007\/s40259-018-0295-0","volume":"32","author":"Bittner","year":"2018","journal-title":"BioDrugs"},{"key":"ref13","unstructured":"European Medicines Agency. List of nationally authorised medicinal products: active substance Glatiramer (Procedure no.: PSUSA\/00001529\/202011). 2021."},{"key":"ref14","unstructured":"Medicines Evaluation Board (MEB). Glatiramer acetate: public assessment report, scientific discussion. 2016."},{"key":"ref15","unstructured":"US Food and Drug Administration. Glatiramer Acetate Injection, 40 mg\/mL - ANDA Approval. 2017."},{"key":"ref16","doi-asserted-by":"publisher","first-page":"705","DOI":"10.1002\/ana.23938","volume":"73","author":"Khan","year":"2013","journal-title":"Ann. Neurol."},{"key":"ref17","unstructured":"US Food and Drug Administration. Copaxone (glatiramer acetate): approval package. 2014."},{"key":"ref18","doi-asserted-by":"publisher","first-page":"77","DOI":"10.17925\/ENR.2010.05.02.77","volume":"5","author":"Kozubski","year":"2010","journal-title":"European Neurol Rev"},{"key":"ref19","doi-asserted-by":"publisher","first-page":"A63","DOI":"10.1016\/j.jval.2014.03.371","volume":"17","author":"Narayanan","year":"2014","journal-title":"Value Health"},{"key":"ref20","doi-asserted-by":"publisher","first-page":"173","DOI":"10.2147\/PPA.S14903","volume":"5","author":"Verdun Di Cantogno","year":"2011","journal-title":"Patient Prefer Adherence"},{"key":"ref21","doi-asserted-by":"publisher","first-page":"1205","DOI":"10.1016\/j.jsps.2021.09.004","volume":"29","author":"Roy","year":"2021","journal-title":"Saudi Pharm J"},{"key":"ref22","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1517\/17425247.2013.763793","volume":"10","author":"Bayas","year":"2013","journal-title":"Expert Opin Drug Delivery"},{"key":"ref23","unstructured":"Glatiramer acetate - copaxone - CSYNC autoinjector user guide. 2014. Available from: https:\/\/products.tevauk.com\/media\/download\/45818. Accessed December 04, 2024."},{"key":"ref24","unstructured":"Health products regulatory authority - Ireland. brabio 20 mg\/mL solution for injection, pre-filled syringe. Available from: https:\/\/www.hpra.ie\/img\/uploaded\/swedocuments\/Licence_PA23266-010-001_17112023150542.pdf. Accessed December 04, 2024."},{"key":"ref25","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1080\/17425247.2018.1407755","volume":"15","author":"Wray","year":"2018","journal-title":"Expert Opin Drug Delivery"},{"key":"ref26","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1007\/s40120-016-0047-3","volume":"5","author":"Barone","year":"2016","journal-title":"Neurol Ther"},{"key":"ref27","doi-asserted-by":"publisher","first-page":"1325","DOI":"10.2147\/PPA.S137741","volume":"11","author":"Limmroth","year":"2017","journal-title":"Patient Prefer Adherence"},{"key":"ref28","doi-asserted-by":"publisher","first-page":"1413","DOI":"10.2147\/PPA.S169339","volume":"12","author":"Tischer","year":"2018","journal-title":"Patient Prefer Adherence"},{"key":"ref29","doi-asserted-by":"publisher","first-page":"537","DOI":"10.1007\/s40744-020-00216-5","volume":"7","author":"Rekaya","year":"2020","journal-title":"Rheumatol Ther"},{"key":"ref30","first-page":"225","volume":"10","author":"Costello","year":"2008","journal-title":"Medscape J Med"},{"key":"ref31","doi-asserted-by":"publisher","first-page":"255","DOI":"10.2147\/MDER.S85938","volume":"8","author":"Lange","year":"2015","journal-title":"Med Devices"},{"key":"ref32","doi-asserted-by":"publisher","first-page":"126","DOI":"10.1186\/1471-2377-11-126","volume":"11","author":"Phillips","year":"2011","journal-title":"BMC Neurol"},{"key":"ref33","doi-asserted-by":"publisher","first-page":"951","DOI":"10.2147\/PPA.S85917","volume":"9","author":"Weller","year":"2015","journal-title":"Patient Prefer Adherence"}],"container-title":["Degenerative Neurological and Neuromuscular Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.dovepress.com\/article\/download\/98640","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.dovepress.com\/article\/download\/98640","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,12,21]],"date-time":"2024-12-21T06:30:16Z","timestamp":1734762616000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.dovepress.com\/autoinjectors-for-administering-glatiramer-acetate-in-relapsing-remitt-peer-reviewed-fulltext-article-DNND"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,12]]},"references-count":33,"URL":"https:\/\/doi.org\/10.2147\/dnnd.s484306","relation":{},"ISSN":["1179-9900"],"issn-type":[{"value":"1179-9900","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,12]]}}}